OA05.03 Single-Agent Rovalpituzumab Tesirine, a Delta-Like Protein 3 (DLL3)-Targeted Antibody-Drug Conjugate (ADC), in Small-Cell Lung Cancer (SCLC)
Year: 2017
Type: conference-abstract
Source: Journal of Thoracic Oncology
Authors: David Spigel, M Catherine Pietanza, Todd Bauer, Neal Ready, Daniel Morgensztern, Bonnie S. Glisson, Lauren Averett Byers, Melissa Johnson, Howard Burris, Francisco Robert, Tae Han, Sheila Bheddah, Noah Theiss, Sky Watson, Deepan Mathur, Bharathi Vennapusa, Donald Strickland, Hany Zayed, Scott Dylla, Stanford Peng, Ramaswamy Govindan, Charles Rudin
Language: English
Topic: Lung Cancer Research Studies
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
OpenAlex ID: W2571330605